Gene editing freed sickle cell patients from a lifetime of pain

Sickle cell disease twists red blood cells into rigid sickles that jam blood vessels, causing agony and organ damage. In the RUBY trial, the gene-editing therapy reni-cel corrected patients' own blood stem cells — and most stayed free of pain crises afterward.